Rhenman & Partners hires Camilla Oxhamre Cruse as Portfolio Manager – biotech and pharma. She will have a particular focus on companies within pharmaceutical development. Camilla joins Rhenman & Partners’ investment team of four people, all based in their Stockholm office. Camilla has a master’s degree in biochemistry from Lund University (Lund) and obtained a […]
News
Monthly update – July 2024
Stock markets increased slightly in July with the world index up 1.7 percent, measured in US dollars. A significant rotation from former stock market winners, mainly in technology, to value stocks and smaller companies was an important phenomenon during the month. The technology companies’ reports indicated slightly lower growth momentum, while smaller companies on the […]
Monthly summary – June 2024
Events during the month of June centered on the continuing geopolitical unrest around the world. The war in Ukraine intensified, negotiations to reach a ceasefire in the Gaza Strip failed, and Putin and Kim Jong Un deepened their cooperation. Financially, June saw overall strong equity markets, especially for the technology sector, but consumer-driven companies in […]
Rhenman & Partners celebrates 15 years
On 21 May Rhenman & Partners took the opportunity to celebrate 15 successful years by inviting guests to a seminar in Stockholm. The article below is a summary of the day and captures the key messages from each presentation. Click here to read or download the article as a PDF. Rhenman & Partners celebrates […]
Susanna Urdmark included in The Hedge Fund Journal’s “50 Leading Women in Hedge Funds 2021”
All of us at Rhenman & Partners are very proud and happy to see Susanna Urdmark included in The Hedge Fund Journal’s “50 Leading Women in Hedge Funds 2021”. This is a fantastic recognition of her expertise, dedication and long-standing focus on the healthcare sector. Congratulations Susanna and all the women included in this year’s […]
RHE L/S winner of Hedgeweek European Awards 2021: Best Global Equity Hedge Fund
European institutional investors, high net worth individuals, investment advisors, fund managers, and prime brokers have awarded Rhenman Healthcare Equity L/S the winner of Hedgeweek Awards 2021 in the category ”Best Global Equity Hedge Fund”. Voting took place after a nominating procedure where the specialist newswire Hedgeweek in cooperation with Bloomberg selected the best performing […]
Rhenman & Partners wins prestigious award at the Nordic Hedge Awards: Best Performance Awards for 5 Years
Since inception in June 2009, the fund has had annualised returns of +19% The sector fund Rhenman Healthcare Equity L/S was named a winner at this year’s Nordic Hedge Awards; best-performing Nordic hedge fund for five years. The award was made in the category “Performance Award for 60 Months”. “We are tremendously pleased over this […]
Li-Huei Tsai receives The Hans Wigzell Research Foundation’s science prize amounting to USD 100,000
The Hans Wigzell Research Foundation (Hans Wigzells forskningsstiftelse) will today award its third annual scientific prize to the neuroscientist Professor Li-Huei Tsai at Massachusetts Institute of Technology (MIT) in Cambridge, USA. Professor Tsai is to receive the prize of USD 100,000 for her pioneering research on the causes and possible therapy of Alzheimer’s disease. The […]